Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights from a real-world registry

BACKGROUND: A significant number of patients with atrial fibrillation (AF) on direct oral anticoagulants (DOACs) receives off-label or inappropriate doses. This study examines the prevalence, dosages, and clinical outcomes in AF-patients on DOAC therapy admitted to an emergency department …